On 24/8/2020 i posted an analysis on this stock being over valued. The min entry price of $57.
AstraZeneca starts U.S final-stage trial of covid-19 vaccine have meant that BNTX is behind the race, but that also means speculators will come in long soon.
Look for short term buying opportunities to price of $70.
DO Not hold this high growth stock, dangerous.
AstraZeneca starts U.S final-stage trial of covid-19 vaccine have meant that BNTX is behind the race, but that also means speculators will come in long soon.
Look for short term buying opportunities to price of $70.
DO Not hold this high growth stock, dangerous.
Komen:
entered at $57